Real-world (RW) study of metastatic colorectal cancer (mCRC) patients (pts) with long-term response (LTR) to regorafenib (REG) in the USA: An updated analysis

被引：0
|
作者：
Kim, R. D. [1 ]
Pan, X. [2 ]
Zhang, Y. [2 ]
Lunacsek, O. [2 ]
Pisa, F. [3 ]
Ostojic, H. [4 ]
Peeters, M. [5 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL USA
[2] Bayer Healthcare Pharmaceut Inc, Real World Evidence Oncol, Whippany, NJ 07981 USA
[3] Bayer AG, Real World Evidence Oncol, Berlin, Germany
[4] Bayer Consumer Care AG, Real World Evidence Oncol, Basel, Switzerland
[5] Univ Hosp Antwerp, Ctr Oncol Res, Edegem, Belgium
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
83P
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [21] Regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world (RW) practice: Final analysis of the prospective, observational REFINE study by prior liver transplantation (PLT)
    Pinter, M.
    Kim, Y. J.
    Merle, P.
    Finn, R. S.
    Khan, J.
    Ozgurdal, K.
    Qin, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S611 - S611
  • [22] Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study
    Merle, P.
    Lim, H. Y.
    Finn, R. S.
    Ikeda, M.
    Kudo, M.
    Frenette, C.
    Masi, G.
    Kim, Y. J.
    Gerolami, R.
    Kurosaki, M.
    Numata, K.
    Klumpen, H-J.
    Zebger-Gong, H.
    Fiala-Buskies, S.
    Ozgurdal, K.
    Qin, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S699 - S700
  • [23] Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
    Patel, Anuj K.
    Barghout, Victoria
    Yenikomshian, Mihran A.
    Germain, Guillaume
    Jacques, Philippe
    Laliberte, Francois
    Duh, Mei S.
    ONCOLOGIST, 2020, 25 (01): : E75 - E84
  • [24] Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidence
    Cervantes, Andres
    Tabernero, Josep
    Garcia-Carbonero, Rocio
    Sastre, Javier
    Feliu, Jaime
    Guillen-Ponceg, Carmen
    Paredes, Beatriz Garcia
    Carral, Alberto
    Munoz, Jorge
    FUTURE ONCOLOGY, 2024, 20 (20) : 1401 - 1413
  • [25] Retrospective analysis of patients (pts) with metastatic melanoma (MM) showing long-term response (LTR) to vemurafenib (Vb).
    Galli, Giulia
    Di Guardo, Lorenza
    Cimminiello, Carolina
    Cavalieri, Stefano
    Rodolfo, Monica
    Rivoltini, Licia
    Valeri, Barbara
    Bono, Aldo
    Tolomio, Elena
    Del Vecchio, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] A multiple centers real-world study of regorafenib treatment modalities in Chinese metastatic colorectal cancer patients.
    Li, Xia Fen
    Luo, Huiyan
    Wang, Zhiqiang
    Xiao, Jian
    Peng, Jianjun
    Wang, Zi-xian
    Zhai, Xiaohui
    Xu, Rui-hua
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15543 - E15543
  • [27] Real-world dosing patterns of regorafenib in patients with metastatic colorectal cancer in Spain: The RE-SEARCH study
    Lopez Munoz, A.
    Gonzalez-Flores, E.
    Afonso, R.
    Carral Maseda, A.
    Pimentel, P.
    Lopez-Lopez, C.
    Jimeno, R.
    Fuentes Mateos, R.
    Reina Zoilo, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S14 - S15
  • [28] Results of a retrospective multicenter study comparing the effectiveness of regorafenib and the rechallenge of chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC)
    Kuzmina, Evgenia
    Fedyanin, Mikhail
    Reshetov, Igor
    Parts, Sergey
    Pokataev, Ilya
    Polyanskiy, Maxim
    Antonova, Tatiana
    Pikulin, Dmirii
    Arseneva, Evgenia
    Anikina, Marina
    Golubev, Pavel
    Syskova, Anna
    Galkin, Vsevolod
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study
    Munoz, Ana Maria Lopez
    Flores, Encarnacion Gonzalez
    Maseda, Alberto Carral
    Caceres, Paola Pimentel
    Gomez, Ruth Afonso
    Lopez, Carlos Lopez
    Mate, Raquel Jimeno
    Zoilo, Juan Jose Reina
    Lopez, Carmen Castanon
    Fernandez, Mercedes Salgado
    Urtasun, Jorge Aparicio
    Martinez, Elena Asensio
    Gomez, Teresa Martin
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (03): : 1176 - 1184
  • [30] Impact of time to treatment initiation on real-world (RW) outcomes in metastatic colorectal cancer (mCRC) in the United States.
    Gbolahan, Olumide B.
    Outlaw, Darryl Alan
    Hashemi, Neda
    Paluri, Ravi Kumar
    Williams, Grant Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345